Outbreak of endemic carbapenem-resistant <i>Acinetobacter baumannii</i> in a coronavirus disease 2019 (COVID-19)–specific intensive care unit
Danielle Rosani Shinohara, Sílvia Maria dos Santos Saalfeld, Hilton Vizzi Martinez, Daniela Dambroso Altafini, Bruno Buranello Costa, Nayara Helisandra Fedrigo, Maria Cristina Bronharo Tognim
Abstract
practices reported increases in BSIs. Ultimately, our understanding of the impact of the COVID-19 pandemic on HAIs will be limited, due in part to the relaxation of mandatory reporting requirements during the pandemic. 1 Data on healthcare-associated noncentral-catheter-associated BSI rates will be particularly limited because reporting in the United States is not mandated.
Topics & Concepts
OutbreakAcinetobacter baumanniiCoronavirus disease 2019 (COVID-19)Intensive care unit2019-20 coronavirus outbreakMedicineInfection controlVirologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MicrobiologyDiseaseBiologyInfectious disease (medical specialty)Intensive care medicineBacteriaPseudomonas aeruginosaInternal medicineGeneticsAntibiotic Resistance in BacteriaAntibiotic Use and ResistanceVibrio bacteria research studies